AdipoRon and ADP355, adiponectin receptor agonists, in Metabolic-associated Fatty Liver Disease (MAFLD) and Nonalcoholic Steatohepatitis (NASH): A systematic review
Sandra Maria Barbalho, Nahúm Méndez‐Sánchez, Lucas Fornari Laurindo
Topics & Concepts
AdiponectinNonalcoholic fatty liver diseaseSteatohepatitisSteatosisFatty liverAdiponectin receptor 1Systematic reviewClinical trialBioinformaticsLiver diseaseMedicineDiseaseInsulin resistanceBiologyInternal medicineMEDLINEInsulinBiochemistryLiver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic DiseasesLipid metabolism and disorders